Regulation of cardiovascular calcification by lipids and lipoproteins.
Regulation of cardiovascular calcification by lipids and lipoproteins.
复制标题
DOI:
10.1097/mol.0000000000000844
复制
发表时间:
2022-10-01
影响因子:
4.4
通讯作者:
Demer, Linda L.
中科院分区:
文献类型:
--
作者:
Hsu, Jeffrey J.;Tintut, Yin;Demer, Linda L.
Lipids and lipoproteins have long been known to contribute to atherosclerosis and cardiovascular calcification. One theme of recent work is the study of lipoprotein (a) [Lp(a)], a lipoprotein particle similar to LDL-cholesterol that carries a long apoprotein tail and most of the circulating oxidized phospholipids. In vitro studies show that Lp(a) stimulates osteoblastic differentiation and mineralization of vascular smooth muscle cells, while the association of Lp(a) with coronary artery calcification continues to have varying results, possibly due to the widely varying threshold levels of Lp(a) chosen for association analyses. Another emerging area in the field cardiovascular calcification is pathological endothelial to mesenchymal transition (EndMT), the process whereby endothelial cells transition into multipotent mesenchymal cells, some of which differentiate into osteo-chondrogenic cells and mineralize. The effects of lipids and lipoproteins on EndMT suggest they modulate cardiovascular calcification through multiple mechanisms. There are also emerging trends in imaging of calcific vasculopathy, including: intravascular optical coherence tomography for quantifying plaque characteristics, positron emission tomography with a radiolabeled NaF tracer, with either CT or MRI to detect coronary plaque vulnerability. Recent work in this field includes studies of Lp(a), EndMT, and new imaging techniques.
影响因子:
2.3
作者:
Mao, Yongzhong;Jiang, Ling
通讯作者:
Jiang, Ling